Pennsylvania Senate Bill 1439 tightens oversight of the state's health insurance exchange by requiring insurers to provide documentary proof of residency and legal status for every enrollee. The bill mandates that the exchange authority respond to insurer requests to cancel policies within one business day and make a final decision within five business days. Additionally, it requires the creation of an Office of Fraud Prevention within 180 days to investigate complaints, standardize reporting forms, and ensure staff receive annual anti-fraud training. The exchange authority must also submit an annual report to state legislators detailing fraud statistics, financial impacts, and implemented procedures.
This bill updates Pennsylvania's Human Services Code to establish stricter rules for when individuals can switch managed care health plans. It requires people who qualify for public assistance to stay in their current plan for at least twelve months unless they meet specific criteria to change. The law allows switching without a reason during a short window after first joining a plan, once a year during a designated enrollment period, or at any time for documented "good cause" such as moving, religious objections, or poor quality of care. To approve a switch based on quality issues, the department must review objective evidence like medical records or official complaints rather than relying on general dissatisfaction. The state must also follow federal regulations when implementing these changes and provide a process for appealing denied requests.
This bill establishes a regulatory framework for the sale of kratom products in Pennsylvania, requiring businesses to register with the Department of Health and prohibiting the sale of synthetic kratom varieties. It mandates that retailers verify customers are at least 21 years old using electronic ID scanners and strictly forbids sharing this data, while also enforcing specific labeling and child-resistant packaging requirements. Additionally, the legislation imposes a tax on natural kratom products and outlines penalties for violations, aiming to standardize oversight and protect public health.
This bill establishes rules requiring the Pennsylvania Department of Human Services to deny payments for medical claims that violate specific federal funding limits on services provided to minors. It mandates that the department and the Office of Attorney General investigate any suspected violations of these payment restrictions by healthcare facilities or practitioners. If a provider is found to have knowingly submitted non-compliant claims, the bill allows for the suspension of their eligibility to receive state funds and requires them to repay between two and three times the amount of the invalid claim. Additionally, the legislation imposes penalties for failing to produce records or cooperate with investigations into these compliance issues.
This bill repeals the Pennsylvania Medical Education Loan Assistance Program, which previously provided financial incentives to students pursuing medical, nursing, biomedical, and life sciences education. The program allowed eligible students to access loans with favorable terms, including low interest rates and fees, to encourage them to practice medicine or nursing in Pennsylvania, particularly in underserved areas. By removing this legislation, the state will no longer administer this specific loan assistance program for medical education.
This bill establishes a fee program for certain nonemergency medical services provided to inmates in Pennsylvania prisons, with fees capped at $1 per service when requested by the inmate. It requires the Department of Corrections to create regulations specifying which medical services incur fees, their amounts, and payment procedures while exempting medical emergencies, chronic care, and preexisting conditions from fees. The legislation also mandates that inmates pay for medical services related to injuries they caused to themselves or other inmates. The Department of Corrections must update existing rules to align with these changes within 180 days of the bill's effective date, which is set to occur 60 days after enactment.
HB 2158 amends Pennsylvania's Controlled Substance Act by adding specific kratom-related compounds to Schedule I, the most restrictive category for controlled substances. The bill prohibits possession, sale, or distribution of any product containing 7-hydroxymitragynine at 2% or more of total alkaloids, or synthetic versions of kratom alkaloids like mitragynine. This change directly affects businesses selling kratom products and individuals who use such substances, making them illegal without medical authorization. The policy change aligns with existing Schedule I criteria of high abuse potential and no accepted medical use.
HB 2111 amends Pennsylvania's abortion laws to restrict public facilities and funds. It prohibits publicly owned hospitals, clinics, or government entities from leasing property, entering contracts, or using public funds to support abortion services - except for cases where abortion is necessary to save a mother's life, or to terminate pregnancies resulting from rape or incest that have been reported to law enforcement (with specific documentation requirements). The bill also bans public funds from being used for legal services related to abortion access or restrictions, and requires strict verification of rape/incest reports before funding can be approved for those exceptions. These changes directly affect public health facilities, government agencies, and providers receiving public funding.
HB 1494 would amend Pennsylvania's Controlled Substance Act to allow ivermectin (for human use) to be sold over-the-counter without a prescription or consultation with a healthcare provider. This change directly affects consumers who can purchase ivermectin at pharmacies or stores without needing a doctor's visit, and pharmacies that would sell it. The bill specifies that ivermectin must be "suitable for human use" to qualify as an over-the-counter medication under state law. It takes effect 60 days after enactment, making this a concrete policy shift in how the medication is distributed in Pennsylvania.
HB 2005 would amend Pennsylvania's abortion-related statutes to require specific medical consultations and informed consent procedures before an abortion can be performed. The bill would mandate that healthcare providers discuss certain medical details and ensure patients understand the procedure and potential risks. This applies directly to licensed physicians and clinics providing abortion services in Pennsylvania. The bill is currently pending in the Judiciary Committee after recent committee actions, but has not yet been voted on by the full legislature.
